ClinicalTrials.gov record
Recruiting No phase listed Observational Accepts healthy volunteers

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

ClinicalTrials.gov ID: NCT03932786

Public ClinicalTrials.gov record NCT03932786. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)

Study identification

NCT ID
NCT03932786
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Vanderbilt-Ingram Cancer Center
Other
Enrollment
900 participants

Conditions and interventions

Interventions

  • Biospecimen collection Procedure
  • Laboratory Biomarker Analysis Other
  • Quality of life assessment Other
  • Questionnaire administration Other
  • Vision assessment Other

Procedure · Other

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 23, 2019
Primary completion
Dec 31, 2029
Completion
Dec 31, 2030
Last update posted
Sep 18, 2025

2019 – 2031

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Lurie Children's Hospital Chicago Illinois 60611 Recruiting
University of Illinois, Chicago Chicago Illinois 60612 Recruiting
University of Minnesoa Minneapolis Minnesota 55455 Recruiting
Washington School of Medicine at St. Louis St Louis Missouri 63110 Recruiting
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 Recruiting
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 Recruiting
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Recruiting
Texas Childeren's Hospital Houston Texas 77030 Recruiting
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03932786, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2025 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03932786 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →